Rate Video

VJVirtual | New therapies in soft tissue sarcomas

Robin Jones • 28 Apr 2020

Robin Jones, MBBS, MRCP, MD (Res), Royal Marsden NHS Foundation Trust, London, UK, highlights the latest updates on new therapies in soft tissue sarcomas. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

How has the trabectedin extended access program benefited sarcoma patients?

RINGSIDE: Phase II/III trial of AL102 for the treatment of desmoid tumors

Robin Jones • 1 Nov 2022

The significance of interactive and educational meetings for sarcoma

Robin Jones • 9 Feb 2022

Update on the NAVIGATOR study

Robin Jones • 23 Sep 2020

Related Videos

Trabectedin and pazopanib: an indirect comparison of their ability to treat LMS

How has the trabectedin extended access program benefited sarcoma patients?

The current state of drug development against sarcomas

Response rates to immunotherapy in sarcoma patients and implications for future therapies

Gary Schwartz • 3 Jun 2016